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Interferons (IFNs) orchestrate antiviral responses in jawed vertebrates and can be
classified into three types based on different aspects of their genomic organization,
structure and receptors through which they signal and function. Generally, type I and
type III IFNs include cytokines that directly induce an antiviral response, whereas type II
IFNs are well-known for their immunomodulatory role during viral infections. In mammals,
type I IFNs have been shown to also regulate many aspects of B cell development and
differentiation. Yet, these functions have been only faintly investigated for teleost IFNs.
Thus, in the current study, we have examined the effects of a model type I rainbow trout
IFN molecule (IFNa) on blood naïve (IgM+IgD+) B cells, comparing them to those exerted
by type II IFN (IFNγ). Our results demonstrate that IFNa increases the survival of naïve
rainbow trout B cells, in the absence of lymphoproliferative effects, by rescuing them from
spontaneous apoptosis. Additionally, IFNa increased the phagocytic capacity of blood
IgM+IgD+ B cells and augmented the number of IgM-secreting cells in blood leukocyte
cultures. IFNγ, on the other hand, had only minor effects up-regulating IgM secretion,
whereas it increased the phagocytic capacity of IgM− cells in the cultures. Finally, given
the recent identification of 9 mx genes in rainbow trout, we have also established which
of these genes were transcriptionally regulated in blood naïve B cells in response to IFNa.
This study points to a previously undescribed role for teleost type I IFNs in the regulation
of B cell responses.
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INTRODUCTION
Interferons (IFNs) are potent antiviral cytokines induced during the course of viral infections
categorized into three classes (types I, II and III) on the basis of the receptors used,
their genomic organization, sequence or structural homology (1). Although type I and
type II IFNs were originally distinguished on the basis of the cells responsible for their
production, it is now evident that they differ at many levels. Both types of cytokines are
implicated in the response to viral infection, but while type I IFNs are well-known for
their antiviral effects, type II IFNs play immunoregulatory functions during infection (2,
3). Thus, type I IFNs comprise a large family of closely related cytokines classified in
mammals as IFNα, IFNβ, IFNε, IFNκ, IFNω, IFNδ, IFNζ, and IFNτ (3, 4). These cytokines
are produced by almost every cell type upon the recognition of a virus or a virus -like
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stimulus. Once secreted, these IFNs bind to their cell surface
receptor and initiate a signaling cascade that eventually leads
to the transcriptional regulation of hundreds of IFN-stimulated
genes (ISGs) [reviewed in (5)]. Among these type I IFN-induced
proteins, many of them such as Myxovirus resistance (Mx)
proteins directly interfere with viral replication (6). On the
other hand, IFNγ, the only type II IFN found in mammals,
is secreted almost exclusively by NK and T lymphocytes in
response to certain cytokines (7). IFNγ has been shown to induce
nitric oxide (NO) production, phagocytosis, and secretion of
pro-inflammatory cytokines of macrophages, promoting their
polarization to an M1 phenotype (8). IFNγ also plays an
important role in antigen presentation, as it increases MHC II
expression and maturation of macrophages and dendritic cells
(DCs) (8, 9). Interestingly, although only a limited subset of cells
express IFNγ, its receptor is ubiquitously expressed, and through
this interaction, IFNγ is also capable of inducing antiviral effects
similar to those elicited by type I IFNs (10). Mammalian type III
IFNs, on the other hand, constitute a group of four cytokines that
activate a signaling pathway similar to that of type I IFNs through
a specific receptor (11, 12).
In addition to their direct antiviral effects, it has become
evident in mammals that type I IFNs also play pleiotropic
effects during the development and differentiation of B cells
(13). In mice, for example, IFNα/β has been shown to
increase the survival of B cells through a decrease of Fas-
mediated apoptosis (14, 15), and to enhance responses to B
cell receptor (BCR) ligation such as calcium mobilization, IgM
internalization, induction of activation markers or proliferation
(14). Additionally, type I IFNs significantly augment the response
of B cells to Toll-like receptor 7 (TLR7) ligands (16), and
synergize with interleukin 6 (IL6) to promote the differentiation
of B cells to antibody-secreting plasma cells (17). Thus,
mammalian type I IFNs impact B cell functions through a
wide range of direct effects or indirectly by regulating DCs or
macrophages that in turn affect B cell functionality (13, 18, 19). In
this context, it is not surprising that the progression of systemic
autoimmune diseases such as systemic lupus erythematosus
(SLE) often associates with an increased type I IFN production
(13), as IFN levels in SLE patients correlate with autoantibody
production (20).
Teleost fish also possess multiple type I IFNs, varying in
number depending on the fish species [reviewed in (21)]. The
number of type I IFN genes is especially high in particular teleost
lineages such as salmonids, potentially as a consequence of the
additional whole genome duplication (WGD) event that took
place throughout evolution in this lineage. Fish type I IFNs
can be phylogenetically divided into three major groups (22),
classified into 6 subgroups (a, b, c, d, e, and f) in salmonids.
IFNa, IFNd, and IFNe are in Group I, IFNb and IFNc are
in Group II, whilst IFNf is in Group III, with multiple genes
present for most subgroups (23). It is important to clarify that
IFNa and IFNb are not orthologs of mammalian IFNα and
IFNβ. To date, the antiviral activity of several teleost type I
IFNs has been confirmed, including IFNa, IFNb, and IFNc (24–
26). In contrast, IFNd showed little or no antiviral activity in
salmon (or zebrafish) (25, 26). Whilst there is a single gene
for IFNγ in most vertebrate groups, again as a consequence
of WGD, two genes are found in salmonids and cyprinids (27,
28). Although few functional studies have been undertaken in
these species as to whether differences exist between the two
IFNγ paralogs, several independent transcriptional studies show
no major differences concerning their regulatory mechanisms
(27, 29–31). Interestingly, some teleost species [reviewed in
(32)] have an additional IFNγ-like gene designated as IFNγ-
rel that presumably originated from a teleost-specific tandem
duplication. With regard to IFNγ and IFNγ-rel bioactivity, most
assays conducted thus far in teleosts have been predominantly
focused on analyzing its effects on macrophages [reviewed
in (32)].
In teleost fish, three Ig classes have been described to date,
IgM, IgD, and IgT (a teleost-specific Ig) which define different B
cell subsets. IgM+IgD+ constitute the main B cell type in central
immune tissues such as peripheral blood, spleen and head kidney
(the main hematopoietic organ). As described in mammals,
upon activation, these naïve cells loose surface IgD expression
becoming IgM+IgD− cells (33). Additionally, as also reported in
specific human and mice mucosal compartments (34–36), B cells
exclusively expressing IgD on the cell surface have been identified
in catfish (Ictalurus punctatus) blood (37) and rainbow trout
(Oncorhynchus mykiss) gills (38) and intestine (39). The function
of these cells is still unknown. IgT+ cells, on the other hand,
constitute a distinct B cell lineage that seems to be specialized in
mucosal responses, as the ratio of IgT+ B cells to IgM+IgD+ B
cells is higher in mucosal surfaces, and IgT responses have been
shown to be restricted to mucosal compartments in response
to some infections (40, 41). Interestingly, fish IgM+IgD+ B
cells have been shown to share many phenotypic and functional
characteristics of mammalian B1 cells (42, 43), innate B cells that
immediately respond to antigens to produce natural antibodies
that interfere with pathogen replication until a specific immune
response is mounted (44). In this context, it seemed quite relevant
to establish how fish naïve IgM+IgD+ B cells respond to innate
signals produced during the early stages of a pathogenic exposure
such as IFNs.
To date, whether type I or type II IFNs affect B cell
functionality has been only addressed in fish in one study in
which flounder (Paralichthys olivaceus) type I IFN was shown
to enhance the phagocytic capacity of IgM+ B cells as well
as their production of reactive oxygen species (ROS) (45). In
the current study, we have investigated the effects of both
type I and type II IFN on IgM+ B cells using rainbow trout
(Oncorhynchus mykiss) as a model species. For this, we have
stimulated rainbow trout peripheral blood leukocytes (PBLs)
with recombinant trout IFNa and IFNγ (rIFNa and rIFNγ) and
then studied different functions of naïve B cells. We chose to
undertake these studies with PBLs, as in rainbow trout, the blood
is where the higher percentage of IgM+IgD+ B cells are found,
∼44% (46). Our results demonstrate that while IFNa regulates
many aspects of B cell functionality, type II IFN only has minor
effects on IgM secretion. The effects of trout IFNa on naïve
B cells include increased survival through decreased apoptosis,
up-regulated phagocytic capacity and augmented IgM secretion
and Mx transcription. However, in contrast to mammalian type
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I IFN, trout IFNa was not capable of synergizing with BCR
signaling. This study thus demonstrates that, in addition to their
direct antiviral effects, teleost type I IFNs play an important
role in the regulation of B cell responses as in mammals. The
differences between the effects exerted in mammals and fish will
most probably be a consequence of the significant differences that
exist between mammalian conventional B cells and fish B cells.
MATERIALS AND METHODS
Experimental Fish
Healthy rainbow trout (Oncorhynchus mykiss) of ∼50–70 g were
obtained from Piscifactoria Cifuentes (Cifuentes, Guadalajara,
Spain) and maintained at the animal facilities of the Animal
Health Research Center (CISA-INIA, Spain) in an aerated
recirculating water system at 15◦C, with a 12:12 h light: dark
photoperiod. Fish were fed twice a day with a commercial diet
(Skretting, Spain). Prior to any experimental procedure, fish were
acclimatized to laboratory conditions for at least 2 weeks. During
this period no clinical signs of disease were ever observed.
Leukocyte Isolation
Rainbow trout were killed with benzocaine (Sigma-Aldrich) and
blood was extracted with a heparinized needle from the caudal
vein. Blood was diluted 10 times with Leibovitz’s medium (L-
15, Gibco) containing 100 I.U./ml penicillin and 100µg/ml
streptomycin (P/S, Life Technologies), 10 I.U./ml heparin and
5% fetal calf serum (FCS, Thermo Fisher Scientific) and then
placed onto 51% Percoll (GE Healthcare) density gradients. Cell
suspensions were centrifuged at 400 × g for 30min at 4◦C, the
interface cells were collected andwashed with L-15 supplemented
with antibiotics and 5% FCS. The viable cell concentration was
determined by Trypan blue (Sigma-Aldrich) exclusion and cells
were resuspended in L-15 with 5% FCS at a concentration of 2×
106 cells/ml.
Production of Recombinant IFNs
rIFNa and rIFNγ were produced as described previously (47,
48). Both recombinant proteins were expressed in Escherichia
coli BL21 Star (DE3) by isopropyl β-D-1-thiogalactopyranoside
(IPTG) induction and purified under denaturing conditions with
extensive washing with buffer containing Triton X-100 to remove
lipopolysaccharide (LPS) as described previously. The purified
proteins were refolded in a buffer containing 0.5M arginine,
and re-purified under native conditions (47–49). The bioactivity
was established by testing their ability to induce the expression
of specific target genes, such as Mx and CXCL11_L1 in vitro
in rainbow trout cell lines such as the monocyte/macrophage
rainbow trout cell line RTS11 (47, 48). Both proteins had no
effects on the expression of known LPS-responsive genes, such as
IL1β and cathelicidin-1 in RTS11 cells (50), confirming the lack
of LPS contamination.
Cell Stimulation
Peripheral blood leukocytes (PBLs), suspended in L-15 medium
supplemented with antibiotics and 5% FCS, were dispensed
into 24 (2 × 106 cells/well) or 96-well plates (4 × 105
cells/well) (Nunc), depending on the experiment. The rIFNa and
rIFNγ were used at a final concentration of 50 and 20 ng/ml,
respectively, after establishing that these were the concentrations
that rendered maximal effects in terms of B cell survival and
mx gene expression (data not shown). These concentrations
are in accordance with previous results (47, 48, 51). Controls
incubated with media alone were included in all experiments.
Leukocytes were cultured at 20◦C for different times, depending
on the experiment.
Flow Cytometry
Cells were stained with anti-trout IgM [1.14 mAb mouse IgG1
coupled to R-phycoerythrin (R-PE), 0.25µg/ml], anti-trout IgD
[mAb mouse IgG1 coupled to allophycocyanin (APC), 4µg/ml]
and anti-trout MHC II β-chain [mAb mouse IgG1 coupled
to fluorescein isothiocyanate (FITC), 4µg/ml] for 1 h at 4◦C,
as previously described (52–54). Antibodies were fluorescently
labeled using R-PE, APC or FITC Lightning-Link labeling kits
(Innova Biosciences) following the manufacturer’s instructions.
After the staining, cells were washed twice with staining buffer
(phenol red-free L-15 medium supplemented with 2% FCS).
The cell viability was checked by addition of 4’,6-diamine-
2’-phenylindole dihydrochlorid (DAPI, 0.2µg/ml). Cells were
analyzed on a FACS Celesta flow cytometer (BD Biosciences)
equipped with BD FACSDivaTM software. Flow cytometry
analysis was performed with FlowJo V10 (TreeStar).
Leukocyte Proliferation
The Click-iTTM Plus EdU Alexa FluorTM 488 Flow Cytometry
Assay Kit (InvitrogenTM) was used to measure the proliferation
of IgM+IgD+ B cells following the manufacturer’s instructions.
PBLs were incubated for 3 days at 20◦C in 96-well plates
with the rIFNs or media alone. In some experiments, PBLs
were also stimulated with unlabelled monoclonal antibody
(mAb) against trout IgM (clone 1.14, mouse IgG1) at a final
concentration of 10µg/ml, to induce cross-linking of the BCR
as described previously (43). After 3 days, 0.1µM of 5-ethynyl-
2’-deoxyuridine (EdU) was added to the cultures that were
further incubated for 24 h. Thereafter, cells were collected and
stained with the LIVE/DEAD R© Fixable Dead Cell Stain Kit
(InvitrogenTM) for 30min at 4◦C (protected from light) to
check cell viability following the manufacturer’s instructions.
Subsequently the cells were stained with anti-trout IgM (1.14
mAb mouse IgG1 coupled to R-PE, 0.25µg/ml) and anti-trout
IgD (mAb mouse IgG1 coupled to APC, 4µg/ml) for 1 h at
4◦C, as described above, and analyzed on a FACS Celesta
flow cytometer.
Apoptosis
The apoptosis assay was performed using the PE Annexin V
Apoptosis Detection Kit I (BD PharmingenTM) following the
manufacturer’s instructions. Briefly, PBLs were incubated for 48
or 72 h at 20◦C in 96-well plates with the rIFNs or with media
alone. Thereafter, cells were stained with anti-trout IgM [1.14
mAb mouse IgG1 coupled to FITC, 0.425µg/ml] for 20min at
4◦C. After washing with staining buffer, the cells were centrifuged
at 400 × g for 5min at 4◦C, and 1.5 µl of PE Annexin V
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and 4 µl of 7-aminoactinomycin D (7-AAD) per 200 µl of 1X
Annex V Binding Buffer added to the cells. The cells were then
incubated for 15min at room temperature (RT) in the dark before
being transferred to flow cytometry tubes (Falcon R© 5mL Round
Bottom Polystyrene Test Tube, Corning) containing 400 µl of
1X Annex V Binding Buffer, and analyzed within 1 h on a FACS
Celesta flow cytometer.
Phagocytic Activity
PBLs were seeded into 24-well plates and incubated for 72 h
at 20◦C with the rIFNs or media alone. The cells were then
collected and resuspended in L-15 medium supplemented with
antibiotics without serum and incubated for 3 h at 20◦C
with fluorescent beads (FluoSpheresTM Carboxylate-Modified
Microspheres, 1.0µm, crimson fluorescent (625/645), 2% solids,
InvitrogenTM) at a cell: bead ratio of 1:10, as described before
(55). After the incubation period, cells were harvested by
gently pipetting, and non-ingested beads were removed by
centrifugation (100 × g for 10min at 4◦C) over a cushion of
3% (weight/volume) bovine serum albumin (BSA) lyophilized
powder, ≥96% (Sigma-Aldrich) in PBS supplemented with 4.5%
(weight/volume) D(+)-glucose monohydrate (Merck). Cells
were then resuspended in staining buffer, labeled with anti-
IgM-FITC (1.14) (0.425µg/ml) and anti-IgD-PE (40µg/ml) and
analyzed on a FACS Celesta flow cytometer. The cell viability
was checked by staining the cells with DAPI (0.2µg/ml). In
some experiments, cytochalasin B (0.05µg/ml) was added to
the cells immediately before the addition of the beads to verify
active phagocytosis as described previously (55). Flow cytometry
analysis was performed with FlowJo V10 to calculate the ratio
between the percentage of phagocytic IgM+ B cells among the
total IgM+ B cell population, the ratio between the percentage of
highly phagocytic IgM+ B cells among the total IgM+ phagocytic
B cell population and the mean fluorescence intensity (MFI) of
internalized beads in all IgM+ phagocytic cells.
ELISPOT Assay
PBLs from individual fish were stimulated with rIFNs for 72 h
at 20◦C or left unstimulated in the same conditions in 96-
well plates. ELISPOT plates containing Inmobilon-P membranes
(Millipore) were activated with 70% ethanol for 30 s, coated
with an anti-IgM mAb (clone 4C10) at 2µg/ml in phosphate
buffer saline (PBS) and incubated overnight at 4?C. To block
non-specific binding to the membrane, plates was incubated
with 2% BSA in PBS for 2 h at RT. At this point, cells that
had been stimulated with rIFNs for 72 h or unstimulated cells
were transferred to the ELISPOT plates (5 × 104 cells/well)
and left overnight at 20◦C. The day after, cells were washed
away five times with PBS and plates blocked again with 2%
BSA in PBS for 1 h at RT. After blocking, biotinylated anti-
IgM mAb (clone 4C10) was added to the plates and incubated
at 1µg/ml for 1 h at RT. Following five washing steps (in
PBS), the plates were developed using streptavidin-HRP (Thermo
Scientific) for 1 h at RT, washed again with PBS and incubated
with 3-amino-9-ethylcarbazole (Sigma-Aldrich) for 30min at
RT in the dark. Substrate reaction was stopped by washing the
plates with tap water. Once the membranes had dried, they
were digitally scanned and the number of spots in each well-
determined using an AID iSpot Reader System (Autoimmun
Diagnostika GMBH).
Cell Sorting
PBLs were seeded into 24-well plates and incubated for 24 h
with rIFNs or with media alone at 20◦C. At this point, cells
were collected and incubated for 1 h at 4◦C with anti-IgM-
FITC and anti-trout IgD-APC as described above. Following
several washing steps, cells were resuspended in staining buffer
and IgM+IgD+ B cells isolated by flow cytometry using a
BD FACSAria III cell sorter (BD Biosciences) based on their
FSC/SSC profile and then on the basis of the fluorescence
emitted by the anti-IgM and anti-IgD antibodies. Approximately
70,000 IgM+IgD+ B cells were collected in PBS for subsequent
RNA isolation.
To confirm a direct effect of rIFNs on IgM+IgD+ B
cell survival, PBLs were incubated for 1 h at 4◦C with a
biotinyilated Fab fragment of anti-IgM 1.14 (to avoid cell
activation) in staining buffer. Following two washing steps,
Streptavidin-Phycoerythrin (PE) (BD Pharmingen) was added.
After 20min at 4◦C, cells were resuspended in staining
buffer and IgM+IgD+ B cells isolated as described above.
Sorted IgM+IgD+ B cells were then incubated with rIFNs or
media alone for 3 days at 20◦C. After this time, cells were
counterstained with 0.2µg/ml DAPI, and analyzed on a FACS
Celesta flow cytometer.
Real Time PCR Analysis
Total RNA was isolated from FACS sorted IgM+IgD+ B cells
using the Power SYBR Green Cells-to-Ct Kit (Invitrogen),
following the manufacturer’s instructions. Briefly, total RNA
was treated with DNase during the process to remove genomic
DNA that might interfere with the PCR reactions and then
reverse transcribed into cDNA following the manufacturer’s
instructions. To evaluate the levels of transcription of the
different genes, real time RT-PCR was performed with a
LightCycler R© 96 System instrument (Roche) using SYBR Green
PCR core Reagents (Applied Biosystems) and specific primers
(Table S1). Samples obtained from individual fish were analyzed
in duplicate under the following conditions: 1min at 95◦C,
followed by 45 amplification cycles (15 s at 95◦C and 1min
at 60◦C). A melting curve for each primer set was obtained
by reading fluorescence every degree between 60 and 95◦C to
ensure that only a single PCR product had been amplified.
The expression of individual genes was normalized to the
relative expression of the housekeeping gene β-actin, and
the expression levels were calculated using the 2( − 1Ct)
method, where 1Ct is determined by subtracting the β-
actin value from the target Ct (Ct cut-off set to 38). This
housekeeping gene was selected after verifying that no statistical
differences were detected among β-actin Ct values obtained
from different samples. Negative controls with no template
and minus reverse transcriptase controls were included in all
the assays.
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FIGURE 1 | Survival of blood IgM+ IgD+ B cells in response to type I and type II IFNs. PBLs were stimulated with 50 ng/ml rIFNa, 20 ng/ml rIFNγ or media alone
(control) and cultured at 20◦C for 72 h. Leukocytes were then labeled with specific monoclonal antibodies against trout IgM and IgD and analyzed by flow cytometry.
(Continued)
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FIGURE 1 | Cells were gated on the basis of their FSC and SSC and percentages of IgM+ IgD+ cells determined on singlet and live (DAPI negative) cells.
Representative dot plots from one individual fish are shown (A) along with mean percentages and total number of cells detected for IgM+ IgD+ B cells (B) and
IgM− IgD− cells (C) (mean + SEM; n = 9). In an independent experiment, B cells were sorted from blood leukocytes using a biotinyilated Fab fragment of anti-IgM
1.14 and then incubated with the rIFNs as described above. After 72 h, the percentage of live IgM+ IgD+ B cells and the total number of live IgM+ IgD+ B cells
determined by flow cytometry as described in the Materials and Methods section (mean + SEM; n = 7) (D). Asterisks denote significant differences between samples
treated with rIFNs and control samples (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001).
FIGURE 2 | Proliferative effects of type I and type II IFNs on blood IgM+ IgD+ B cells. The lymphoproliferative effects of rIFNa and rIFNγ were determined by incubating
PBLs at 20◦C with 50 ng/ml rIFNa, 20 ng/ml rIFNγ or media alone. For each condition, wells containing 10µg/ml of unlabelled anti-IgM were also included. After 72 h,
cells were labeled with EdU (1µM) and incubated for a further 24 h. At that point, cells were labeled with anti-IgM and anti-IgD mAbs and the percentage of IgM+ IgD+
B cells with incorporated EdU (proliferating cells) determined as described in the Materials and Methods section. Representative dot plots are presented along with a
graph showing the quantification of proliferating IgM+ IgD+ B cells (mean + SEM; n = 8).
Statistical Analysis
Data handling, analysis and graphic representation were
performed using GraphPad Prism version 7.00 for Windows,
GraphPad Software, La Jolla California USA (www.graphpad.
com). Statistical analyses were performed using a two-tailed
Student’s t-test and the differences between the mean values were
considered significant when P ≤ 0.05.
RESULTS
Type I IFNa Increases the Survival of
IgM+IgD+ B Cells by Decreasing Their
Spontaneous Apoptosis
Our results show that the incubation of rainbow trout PBLs with
rIFNa significantly increased the survival of IgM+IgD+ B cells
after 72 h (Figures 1A,B). In this and all other flow cytometry
experiments described throughout the paper with the exception
of the apoptosis assays, doublets and dead cells were excluded
from the analysis following the gating strategy described in
Figure S1. rIFNa significantly increased both the percentage of
IgM+ B cells and the absolute number of IgM+ B cells in the
cultures (Figures 1A,B), while rIFNγ only had a significant effect
increasing the absolute number of IgM+ B cells in the cultures but
had no effect on the percentage of IgM+ B cells (Figures 1A,B).
rIFNγ had no effect on the survival of the IgM− leukocyte
population, whereas rIFNa provoked a slight but significant
down-regulation of the percentage and the total number of IgM−
cells in the cultures (Figures 1A,C). In these experiments, rIFNa
and rIFNγ were used at their optimal concentrations (50 ng/ml
and 20 ng/ml, respectively), as established before (47, 48, 51),
and in preliminary experiments, where in the case of rIFNγ
higher concentrations (50 ng/ml) had similar or even lower
effects on IgM+IgD+ B cells (Figure S2). As this effect of rIFNa
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FIGURE 3 | Effect of type I and type II IFNs on the spontaneous apoptosis of blood IgM+ IgD+ B cells. PBLs were incubated for 48 h (A) or 72 h (B) at 20◦C with
50 ng/ml rIFNa, 20 ng/ml rIFNγ or media alone (control). Then, cells were stained with anti-trout IgM for 20min at 4◦C. After washing, PE Annexin V and 7-AAD were
(Continued)
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FIGURE 3 | used to stain the cells and identify early (Annexin V+/7-AAD−) and late (Annexin V+/7-AAD+) apoptosis. Data were analyzed within 1 h as described in the
Materials and Methods section. Representative dot plots are presented along with graphs showing the quantification of apoptotic IgM+ B cells (mean + SEM; n =
6–9). Asterisks denote significant differences between samples treated with rIFNs and control samples (*P ≤ 0.05).
on IgM+IgD+ B cells could have been indirect, we repeated the
experiments in such a way that IgM+IgD+ B cells were first
sorted with an anti-IgM Fab and then stimulated with the rIFNs.
The purity of the sorted B cell population was evaluated by flow
cytometry (Figure S3). In this case again, only rIFNa significantly
increased the survival of IgM+IgD+ B cells, demonstrating a
direct effect of this cytokine on survival (Figure 1D).
To determine whether this increased survival of B cells in
the presence of rIFNa was a consequence of lymphoproliferative
effects of this cytokine, we analyzed the proliferative effect
of rIFNa and rIFNγ on their own or when combined with
BCR cross-linking (through incubation with anti-IgM). Our
results clearly showed that none of the rIFNs exerted significant
proliferative effects on rainbow trout blood IgM+IgD+ B cells
by themselves (Figure 2). No synergistic effects were observed
between BCR cross-linking and rIFN stimulation (Figure 2).
Another possible mechanism through which rIFNa could
increase the survival of IgM+IgD+ B cells may be through
the modulation of spontaneous apoptosis of these cells. To
test this, we studied apoptosis of IgM+IgD+ B cells after
48 or 72 h of incubation with the different rIFNs. In these
experiments, the leukocyte population was gated and doublets
excluded from the analysis as described in Figure S1, although
in this case the viability marker used was 7-AAD. Both
after 48 and 72 h, a significant decrease in the percentage of
early (Annexin V+/7-AAD−) and late (Annexin V+/7-AAD+)
apoptotic IgM+IgD+ B cells was observed after stimulation with
rIFNa (Figures 3A,B). Interestingly, the percentages of early and
late apoptotic IgM+IgD+ B cells were quite similar after 48 and
72 h suggesting that B cells are mostly killed during the first
48 h of culture, whereas those that survive after 48 h remain
viable for longer time periods. This effect was not observed
in response to rIFNγ. Altogether, our results demonstrate that
rIFNa increases the survival of blood naïve B cells, rescuing them
from spontaneous apoptosis.
Type I IFNa Increases the Phagocytic
Activity of IgM+IgD+ B Cells
As teleost B cells have been shown to have a potent phagocytic
activity (42), we also investigated if rIFNa and rIFNγ had an
effect on the capacity of IgM+IgD+ B cells to phagocytise
microparticles. For this, PBLs were pre-treated with the rIFNs
and after 72 h, the phagocytosis assay was conducted. Our results
show that the pre-stimulation of IgM+IgD+ B cells with rIFNa
significantly increased the percentage of phagocytic IgM+IgD+ B
cells in the cultures when compared to either unstimulated cells
or those treated with rIFNγ (Figure 4). Additionally, the MFI of
internalized beads in blood IgM+IgD+ B cells was significantly
higher in rIFNa-treated cells compared to controls (Figure 4),
as was percentage of IgM+IgD+ B cells with a high number of
ingested beads (highly phagocytic IgM+IgD+ B cells) (Figure 4).
When we analyzed the effect of these cytokines on the IgM−IgD−
population, we found that in this case IFNa had positive effects
on the percentage of phagocytic cells, whereas both cytokines
increased the percentage of highly phagocytic cells in the cultures
when compared to unstimulated cells.
Type I and Type II IFN Increase IgM
Secretion
We next studied, through ELISPOT, whether the rIFNs affected
the capacity of rainbow trout blood B cells to secrete IgM, by
determining the number of IgM-secreting cells (plasmablasts or
plasma cells) in these PBL cultures. In this case, both rIFNa and
rIFNγ significantly increased the number of IgM-secreting cells
in the cultures after 3 days when compared to the number of
IgM-secreting cells found in non-stimulated cultures (Figure 5),
although the response to rIFNa was significantly higher than that
of rIFNγ.
rIFNs Have No Effect on the Antigen
Presenting Capacities of Blood IgM+IgD+
B Cells
In mammals, IFNγ is one of the main cytokines involved in
stimulating MHC class II expression in antigen presenting cells
(56). Likewise, stimulation of rainbow trout RTS11 macrophages
with 10 ng/ml of rIFNγ significantly increased MHC class II
transcription between 24 and 72 h post-stimulation (51). In this
context, we examined whether rIFNγ and rIFNa could modulate
MHC II expression in blood IgM+IgD+ B cells, as they are
also antigen presenting cells. We first evaluated MHC-II surface
expression by flow cytometry using a specific anti-trout MHC-
II. No significant modulation of MHC II surface expression
(Figure 6A) or MHC II transcription (Figure 6C) was observed
in IgM+IgD+ B cells. Additionally, we evaluated the effect of
rIFNs on the level of transcription of CD80/86 and CD83,
co-stimulatory molecules involved in antigen presentation, and
again no effect was found (Figure 6C). Interestingly, both rIFNa
and rIFNγ significantly increased the levels of surface MHC II
in IgM− cells in these cultures (Figure 6B). These results suggest
that rIFNa and rIFNγ do not modulate the antigen presenting
capacities of rainbow trout B cells, despite having effects on other
antigen presenting cells, possibly monocytes/macrophages.
Type I IFNs Induce the Transcription of
Several Mx Proteins in Blood IgM+IgD+ B
Cells
Mx proteins are dynamin-like GTPases, which play an important
role in antiviral immunity (57) Mammalian Mx expression is
generally induced by type I and type III IFNs but not by type II
IFN (58), although some exceptions to this general rule have been
found recently in teleost fish (59). Interestingly, it has also been
shown recently that the Mx family of proteins has expanded in
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FIGURE 4 | Effect of type I and type II IFNs on the phagocytic capacity of blood IgM+ IgD+ B cells. PBLs were incubated for 72 h at 20◦C with 50 ng/ml rIFNa,
20 ng/ml rIFNγ or media alone (control). After this time, cells were incubated with crimson red fluorescent beads (1µm diameter) at a ratio of 1:10 (cells/ beads) for a
further 3 h at 20◦C and the phagocytic capacity of B cells established as described in materials and methods. Representative dot plots for each experimental
condition are shown. The rectangular areas contain the highly phagocytic cell subpopulations (cells that have internalized a higher number of beads) among IgM+
(upper) or IgM− (lower) cell sub-populations. Upper graphs show the percentage of phagocytic IgM+ B cells within the total IgM+ B cell population (left), the
percentage of highly IgM+ phagocytic cells within the total phagocytic IgM+ B cell population (middle) and the mean fluorescence intensity (MFI) of internalized beads
within phagocytic IgM+ B cells (right). Lower graphs show the same information for the IgM− population. Data are means + SEM; n = 10. Asterisks denote significant
differences between samples treated with rIFNs and control samples (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001).
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FIGURE 5 | Effect of type I and type II IFNs on the differentiation of IgM+ IgD+ B cells to IgM-secreting cells. PBLs were treated with 50 ng/ml rIFNa, 20 ng/ml rIFNγ or
media alone (control) and incubated for 72 h at 20◦C. Thereafter, cells were added to ELISPOT plates, previously coated with anti-IgM mAb (2µg/ml), and incubated
for a further 24 h. The number of IgM-secreting cells was then detected as described in Materials and Methods. Representative wells from one individual are shown
along with the quantification of spot-forming cells (mean + SEM; n = 12). Asterisks denote significant differences between samples treated with rIFNs and control
samples (*P ≤ 0.05, ***P ≤ 0.001).
salmonids, with 10 differentmx genes present in Atlantic salmon
and 9 in rainbow trout (48). However, to date, Mx expression has
not been studied to our knowledge in fish B cells. Our results
demonstrate that rIFNa significantly induced the transcription
of Mx1, Mx3, and Mx5 (Figure 7) in sorted blood IgM+IgD+
B cells and significantly up-regulated the mRNA levels of Mx2,
constitutively transcribed by these cells (Figure 7). rIFNγ, on
the other hand, had no significant effects on Mx transcription
(Figure 7).
DISCUSSION
In addition to the well-known direct antiviral effects of type
I IFNs and the ability of type II IFN to modulate antigen
presentation, it has now become evident that IFNs are also
involved in the regulation of lymphocyte development and
differentiation. However, it is generally believed that B cells
are mainly modulated by type I IFN, while T cells are mostly
responsive to type II IFN (60). To investigate whether fish B
cells are also responsive to type I IFNs, we have studied the
effects of a model type I trout IFN protein (IFNa) on naïve
blood B cells and compared the effects to those elicited by type
II IFN produced under the same conditions. In these assays, the
optimal concentrations for each rIFNwere previously established
and were different for each protein (50 ng/ml for IFNa and
20 ng/ml for IFNγ), in concordance with previous publications
(47, 48, 51). Having said this, all the assays described in the
current study were initially performed with IFNγ at 50 ng/ml but
no significant differences with the results presented here were
found (Figure S2).
The first effect that was clearly visible when PBLs were
incubated with IFNa was that both the percentage of IgM+IgD+
B cells and the absolute number of IgM+IgD+ B cells increased
significantly in the cultures in the presence of the cytokine
after 72 h. As many other leukocyte types were also present in
these cultures, it could have been possible that this increase in
B cells was a consequence of IFNa affecting other cell types
that afterwards activated B cells. For example, mammalian type
I IFN, produced during the course of a viral infection, can
activate DCs and macrophages to produce BAFF and APRIL
which in turn activate B cells (19). Hence, to rule out possible
indirect effects in our experiments, we sorted trout blood B
cells and then stimulated them with rIFNa. In this case, similar
positive effects on B cell survival were observed, pointing to
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FIGURE 6 | Effect of type I and type II IFNs on the antigen-presenting capacities of blood cells. PBLs were incubated with 50 ng/ml rIFNa, 20 ng/ml rIFNγ or media
alone (control) for 72 h at 20◦C. The level of MHC-II surface expression on IgM+ IgD+ B cells and IgM− IgD− cells was then measured via flow cytometry using a
(Continued)
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FIGURE 6 | specific mAb against trout MHC-II. A representative histogram is shown together with a graph of the mean MHC-II MFI values for IgM+ IgD+ B cells (A) or
IgM− IgD− cells (B) (mean + SEM; n = 9). In another experiment, blood leukocytes were treated with the rIFNs as described above and after 24 h IgM+ IgD+ B cells
were sorted by flow cytometry. RNA was extracted to determine the levels of transcription of mhcII, cd83, and cd80/86 (C) by real time PCR. Gene expression data
were normalized against the endogenous control b-actin and are shown as relative expression (mean + SEM; n = 10). Asterisks denote significant differences
between samples treated with rIFNs and control samples (*P ≤ 0.05 and **P ≤ 0.01).
FIGURE 7 | Induction of mx transcription in blood IgM+ IgD+ B cells in response to type I or type II IFNs. Blood leukocytes were incubated with 50 ng/ml rIFNa,
20 ng/ml rIFNγ or media alone (control) at 20◦C. After 24 h, IgM+ IgD+ B cells were sorted by flow cytometry and RNA extracted to determine the levels of transcription
of the different mx genes present in rainbow trout (mx1-mx9). Gene expression data were normalized against the endogenous control b-actin and are shown as relative
expression (mean + SEM; n = 10). Asterisks denote significant differences between samples treated with rIFNs and control samples (*P ≤ 0.05 and **P ≤ 0.01).
a direct effect of the cytokine. This increase in the number
of B cells in PBL cultures was not consequence of IFNa-
induced lymphoproliferative effects as established through in
vitro proliferation assays. In mammals, type I IFN rescues B cells
from Fas induced spontaneous apoptosis through a mechanism
involving phosphorylation of AKT and up-regulation of pro-
survival molecules (14, 15). Hence, we investigated whether this
could be the origin of the increased B cell survival in blood
leukocyte cultures. Our results demonstrated that IFNa provoked
a significant down-regulation of B cell spontaneous apoptosis,
suggesting a similar mechanism to that reported in mammals.
rIFNγ, on the other hand, only increased slightly the absolute
number of IgM+IgD+ B cells in the cultures, but had no effect
on the percentage of IgM+IgD+ B cells. Similarly, there was no
effect of rIFNγ when cells were sorted and then incubated with
the cytokine, nor on B cell apoptosis. Therefore, rIFNγ may be
exerting some minor effects on B cell viability through indirect
mechanisms, but at levels much lower than those described
here for rIFNa. In contrast, rIFNγ had significant effects on the
phagocytic capacity and the levels of surface MHC II expression
of IgM−IgD− leukocytes present in the cultures.
In mammals, type I IFN acts as an amplifier of BCR signaling
during viral infections, by taking the B cells to a state of
partial activation in which cells have a higher sensitivity to
further stimulation through the BCR (14). Thus, type I IFN
significantly enhances responses to BCR ligation that include
proliferation, calcium flux, IgM internalization and induction
of activation markers (14). In rainbow trout, however, rIFNa
did not synergize with BCR signaling to induce proliferation.
The reason for this different response of trout B cells could
be linked to the fact that fish B cells do not proliferate in
response to BCR ligation alone, unlike mammalian conventional
B2 cells but similar to mammalian B1 cells (43). In fact, there
are many other functional and phenotypical similarities between
fish B cells and mammalian innate B1 cells that include a strong
phagocytic capacity, longer survival in cell culture, low IgD
surface expression or expression of B1-specific markers (43).
Interestingly, trout rIFNa was shown to up-regulate one of
these innate features of fish B cells, their phagocytic activity,
significantly increasing the number of phagocytic B cells in the
cultures and the percentage of B cells with a higher number of
phagocytized beads. In this context, it would be interesting to
investigate in mammals the effects of type I IFN in mammalian
B1 cells, and determine for example, whether type I IFN also
induces the phagocytic capacity of these cells as established for
fish B cells.
Mammalian type I IFN has been repeatedly reported
to increase antibody responses in vivo (61, 62). In these
experiments, the increased antibody titers were dependent
on B cells being able to directly respond to IFNα/β (61,
62), demonstrating a direct effect of type I IFN on B cell
differentiation. To investigate if rIFNs on their own were
capable of inducing the differentiation of fish naïve B cells, we
determined the number of IgM-secreting cells in blood leukocyte
cultures after 72 h of exposure. In this case, both rIFNa and
rIFNγ significantly increased the number of plasmablasts/plasma
cells in the cultures, although as observed throughout all the
experiments, the effects of type I IFN were significantly higher
than those of type II IFN. It might be possible that this increase
in the number of IgM-secreting cells is a consequence of a
general increased survival of B cells in the cultures, however,
in agreement with our results, Atlantic salmon IFNa has been
shown to be a potent molecular adjuvant for a DNA vaccine
against infectious salmon anemia virus (ISAV), significantly
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increasing specific IgM titers to the vaccine (63). Furthermore,
when a transcriptomic analysis of the local response to this
plasmid coding for IFNa was undertaken in Atlantic salmon,
IgM, IgD, and IgT were among the genes that were strongly
up-regulated (64).
Mx genes are present in almost all vertebrates, usually as one
to three copies. In mammals, these multiple copies are generally
closely related and have arisen from local gene duplications
(65). However, possibly as a consequence of the third teleost-
specific WGD and a later salmonid-specific WGD, the Mx
gene family, as with many other gene families, has undergone
extensive diversification, with 6–10 different genes identified in
salmonids (48, 59). In rainbow trout, the 9Mx genes present were
constitutively transcribed by RTS11 macrophages, and among
them, Mx1-7 were strongly induced by IFNa while only Mx5
and Mx6 increased their mRNA levels in response to IFNγ (48).
Similarly, in Atlantic salmon, mx genes showed a differential
responsiveness to type I and II IFNs, with those on Chr12 being
highly induced by type I IFNs and those on Chr25 being more
strongly induced by IFNγ than by type I IFN (48, 59). However, to
our knowledge, whichmx genes are expressed in B cells had never
been addressed in teleost fish. Our results suggest that Mx4, Mx7,
Mx8, and Mx9 are not produced by blood B cells, while Mx1,
Mx2, Mx3, and Mx5 were strongly up-regulated in response to
rIFNa (but not IFNγ). Whether this induction of Mx expression
within B cells limits the capacity of viruses to replicate within
these cells is something that should be investigated further, given
that a direct antiviral activity has not yet been demonstrated for
trout Mx proteins.
In conclusion, we report a previously undescribed role
for teleost type I IFN in the regulation of B cell responses.
Our results demonstrate that, as occurs in mammals, IFNa
increased the survival of naïve B cells by rescuing them from
spontaneous apoptosis and increased IgM secretion. However,
unlike mammalian B2 cells, fish B cells treated with type I IFN
did not have an increased responsiveness to BCR stimulation. A
possible explanation for this different response might be linked
to the fact that fish B cells react differently to BCR stimulation
than mammalian conventional B cells. Furthermore, given that
fish B cells actually retain some innate functions such as a strong
phagocytic capacity, we have also established that type I IFN
regulates this activity in fish B cells. Finally, the fact that several
mx genes are induced within B cells as a response to rIFNa points
to an effect limiting the capacity of viruses to replicate within
B cells. Our results provide further evidence of the interplay
between cytokines of the innate immune system and cells of
the adaptive immune system, which is an essential factor in the
regulation of the immune response.
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